ANGIODYNAMICS INC Cash and Equivalents

Quick Answer

ANGIODYNAMICS INC reported Cash and Equivalents of $55.89 million for fiscal year 2025.

ANGIODYNAMICS INC Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $55.89M -26.5%
2024 $76.06M +70.5%
2023 $44.62M +54.8%
2022 $28.82M -40.1%
2021 $48.16M -11.5%
2020 $54.44M -76.1%
2019 $227.64M +207.2%
2018 $74.10M +55.8%
2017 $47.54M +47.0%
2016 $32.33M +75.8%
2015 $18.39M +0.0%
2014 $18.39M +14.2%
2013 $16.11M -32.2%
2012 $23.74M -48.4%
2011 $45.98M -21.7%
2010 $58.76M +110.6%
2009 $27.91M

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
November 30, 2025 $41.64M -23.0% +7.4%
August 31, 2025 $38.76M -29.5% -30.6%
May 31, 2025 $55.89M -26.5% +24.9%
February 28, 2025 $44.76M -42.9% -17.2%
November 30, 2024 $54.09M -11.2% -1.7%
August 31, 2024 $55.01M -4.5% -27.7%
May 31, 2024 $76.06M +70.5% -3.1%
February 29, 2024 $78.45M +160.5% +28.8%
  • ANGIODYNAMICS INC showed a decrease of -26.5% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2009–2025 period, ANGIODYNAMICS INC’s cash and equivalents has grown by 100.3% (from $27.91 million to $55.89 million).
  • The most recent figure is from ANGIODYNAMICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 18, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment